Inductors of interferon for the treatment of recurring anogenital condylomas caused by low-oncogenic types of human papilloma virus

Shperling N.V.; Vengerovskiĭ A.I.; Shperling I.A.; Éngel' E.É.; Zueva A.V.

doi:https://doi.org/

Shperling N.V.

Voenno-meditsinskaia akademiia im. S.M. Kirova, Sankt-Peterburg

Vengerovskiĭ A.I.

Sibirskiĭ gosudarstvennyĭ meditsinskiĭ universitet, Tomsk, Rossiĭskaia Federatsiia

Shperling I.A.

Voenno-meditsinskaia akademiia im. S.M. Kirova, Sankt-Peterburg

Éngel' E.É.

Siberian State Medical University

Zueva A.V.

Siberian State Medical University

Inductors of interferon for the treatment of recurring anogenital condylomas caused by low-oncogenic types of human papilloma virus

Authors:

Shperling N.V., Vengerovskiĭ A.I., Shperling I.A., Éngel' E.É., Zueva A.V.

More about the authors

Journal: Russian Journal of Clinical Dermatology and Venereology. 2010;8(2): 48‑52

Read: 3582 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Shperling NV, Vengerovskiĭ AI, Shperling IA, Éngel' EÉ, Zueva AV. Inductors of interferon for the treatment of recurring anogenital condylomas caused by low-oncogenic types of human papilloma virus. Russian Journal of Clinical Dermatology and Venereology. 2010;8(2):48‑52. (In Russ.)

Подписка 2026 Клиническая дерматология и венерология (Russian Journal of Clinical Dermatology and Venereology)

Использование инфографики авторами научных работ

Close metadata

Recommended articles:

Pathogenetic aspects of autoantibody formation to central nervous system structures in patients with encephalitis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):53-58

Abstract:

Keywords:

papillomavirus infection (PVI)

interferon inducers (IFN)

iodantipirin

cyclopherone

anixin

anogenital condylomas

effectiveness of therapy

Authors:

Shperling N.V.

Voenno-meditsinskaia akademiia im. S.M. Kirova, Sankt-Peterburg

Vengerovskiĭ A.I.

Sibirskiĭ gosudarstvennyĭ meditsinskiĭ universitet, Tomsk, Rossiĭskaia Federatsiia

Shperling I.A.

Voenno-meditsinskaia akademiia im. S.M. Kirova, Sankt-Peterburg

Éngel' E.É.

Siberian State Medical University

Zueva A.V.

Siberian State Medical University

Close metadata

References:

Kulakov V.I. Infektsii, peredavaemye polovym putem - problema nastoyashchego i budushchego. Akush i gin 2003; 6: 3-6.
Jenkins D. Diagnosis of human papillomaviruses: recent advances. Curr Opin Dis 2001; 14: 1: 53-62.
Podistov Yu.I. Rol' virusa papillomy v razvitii predraka i raka sheiki matki. Tsitologiya 2003; 5: 44-50.
Prilepskaya V.N. Genital'nye infektsii i patologiya sheiki matki. M: Medinform, 2008; 384.
Gomberg M.A., Solov'ev A.M. Lechenie porazhenii anogenital'noi oblasti, vyzvannykh papillomavirusnoi infektsiei. Soobshchenie 1. Vestn dermatol venerol 1998; 2: 22-26.
Isakov V.A., Ermolenko D.K., Kutueva F.R. i dr. Ispol'zovanie tsikloferona v terapii papillomavirusnoi infektsii. Rekomendatsii dlya vrachei. St-Peterburg-Velikii Novgorod 2007; 64.
Ershov F.I., Kiselev O.I. Interferony i ikh induktory (ot molekul do lekarstv). M: GEOTAR-Med 2005; 368.
Kubanov A.A. Sovremennye metody diagnostiki virusa papillomy cheloveka. Vestn dermatol venerol 2005; 1: 26-35.
Bontkes H.J., de Gruijl T.D., Walboomers J.M. et al. Assessment of cytotoxic T-lymphocyte phenotype using the, specific merkers granzyme B and TIA-1 in cervical neoplastic lesions. Br J Cancer 1997; 76: 7: 1353-1360.
Frazer I.H. The role of the immune system in anogenital human papillomavirus. Austral J Dermatol 1998; 39: 1: 5-7.
Evstropov A.N. Eksperimental'naya khimioterapiya virusnykh infektsii nesteroidnymi protivovospalitel'nymi sredstvami i ikh kombinatsiei s protivovirusnymi lekarstvennymi preparatami: Avtoref. dis. …d-ra med nauk. M 1992; 48.
Saratikov A.S., Naumova A.V. Iodantipirin - protivovirusnyi preparat. 2-ya Mezhregion farmatsevt konf «Sibirskaya farmatsiya na rubezhe KhKhI veka». Mat konf. Novosibirsk 2000: 108-110.
Romantsov M.A., Kleimenov V.V. Induktor interferona - tsikloferon v klinicheskoi praktike. Vrach 1997; 8: 30-34.